rs72655395

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_198999.3(SLC26A5):​c.1515-44C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00443 in 1,551,366 control chromosomes in the GnomAD database, including 248 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 128 hom., cov: 32)
Exomes 𝑓: 0.0024 ( 120 hom. )

Consequence

SLC26A5
NM_198999.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.143

Publications

2 publications found
Variant links:
Genes affected
SLC26A5 (HGNC:9359): (solute carrier family 26 member 5) This gene encodes a member of the SLC26A/SulP transporter family. The protein functions as a molecular motor in motile outer hair cells (OHCs) of the cochlea, inducing changes in cell length that act to amplify sound levels. The transmembrane protein is an incomplete anion transporter, and does not allow anions to cross the cell membrane but instead undergoes a conformational change in response to changes in intracellular Cl- levels that results in a change in cell length. The protein functions at microsecond rates, which is several orders of magnitude faster than conventional molecular motor proteins. Mutations in this gene are potential candidates for causing neurosensory deafness. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2009]
SLC26A5 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 61
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 7-103380593-G-A is Benign according to our data. Variant chr7-103380593-G-A is described in ClinVar as Benign. ClinVar VariationId is 676192.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.079 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC26A5NM_198999.3 linkc.1515-44C>T intron_variant Intron 14 of 19 ENST00000306312.8 NP_945350.1 P58743-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC26A5ENST00000306312.8 linkc.1515-44C>T intron_variant Intron 14 of 19 1 NM_198999.3 ENSP00000304783.3 P58743-1
SLC26A5ENST00000393727.5 linkc.1515-44C>T intron_variant Intron 12 of 17 1 ENSP00000377328.1 Q7Z7F4
SLC26A5ENST00000393723.2 linkc.1419-44C>T intron_variant Intron 11 of 16 1 ENSP00000377324.1 P58743-6

Frequencies

GnomAD3 genomes
AF:
0.0231
AC:
3506
AN:
151996
Hom.:
129
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0811
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00694
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000265
Gnomad OTH
AF:
0.0134
GnomAD2 exomes
AF:
0.00619
AC:
1551
AN:
250544
AF XY:
0.00461
show subpopulations
Gnomad AFR exome
AF:
0.0851
Gnomad AMR exome
AF:
0.00383
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000194
Gnomad OTH exome
AF:
0.00213
GnomAD4 exome
AF:
0.00240
AC:
3357
AN:
1399252
Hom.:
120
Cov.:
23
AF XY:
0.00207
AC XY:
1447
AN XY:
699680
show subpopulations
African (AFR)
AF:
0.0850
AC:
2733
AN:
32138
American (AMR)
AF:
0.00417
AC:
186
AN:
44594
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25742
East Asian (EAS)
AF:
0.000102
AC:
4
AN:
39374
South Asian (SAS)
AF:
0.000141
AC:
12
AN:
84940
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53260
Middle Eastern (MID)
AF:
0.00284
AC:
16
AN:
5632
European-Non Finnish (NFE)
AF:
0.0000967
AC:
102
AN:
1055288
Other (OTH)
AF:
0.00522
AC:
304
AN:
58284
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
168
336
503
671
839
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0231
AC:
3521
AN:
152114
Hom.:
128
Cov.:
32
AF XY:
0.0225
AC XY:
1675
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.0813
AC:
3368
AN:
41442
American (AMR)
AF:
0.00693
AC:
106
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000265
AC:
18
AN:
67972
Other (OTH)
AF:
0.0132
AC:
28
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
159
318
477
636
795
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0125
Hom.:
33
Bravo
AF:
0.0257
Asia WGS
AF:
0.00491
AC:
17
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 16, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
2.7
DANN
Benign
0.56
PhyloP100
-0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72655395; hg19: chr7-103021040; API